Matisse Capital’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-58,000
| Closed | -$620K | – | 114 |
|
|
2018
Q4 | $620K | Hold |
58,000
| – | – | 0.78% | 34 |
|
|
2018
Q3 | $885K | Buy |
58,000
+1,000
| +2% | +$15.3K | 0.79% | 36 |
|
|
2018
Q2 | $698K | Hold |
57,000
| – | – | 0.55% | 54 |
|
|
2018
Q1 | $545K | Sell |
57,000
-43,000
| -43% | -$411K | 0.33% | 72 |
|
|
2017
Q4 | $903K | Hold |
100,000
| – | – | 0.41% | 61 |
|
|
2017
Q3 | $575K | Buy |
+100,000
| New | +$575K | 0.27% | 66 |
|